Short answer: if you take birth control pills and start Mounjaro or Zepbound (tirzepatide), the FDA labels say your pill may work less well for a while. They advise switching to a non-pill method, or adding a barrier method such as condoms, for 4 weeks after your first dose and for 4 weeks after every dose increase. The semaglutide labels (Ozempic, Wegovy, Rybelsus) do not carry that advice. If you are planning a pregnancy, the semaglutide labels say to stop at least 2 months before, and the Zepbound label says to stop once a pregnancy is recognized.
Below is what each label says and how to track the 4-week windows. This is general label information, not medical advice.
Why a weekly shot can affect a daily pill
GLP-1 drugs slow how fast food and pills leave your stomach. That is part of how they reduce appetite. A slower stomach can also change how quickly and how much of a pill gets into your blood.
For a birth control pill, which depends on steady hormone levels, that matters.
What the Mounjaro and Zepbound labels say
The Zepbound label on DailyMed (revised 08/2026) says in section 8.3 that tirzepatide "may reduce the efficacy of oral hormonal contraceptives due to delayed gastric emptying." It adds that this delay is largest after the first dose and gets smaller over time.
The advice in sections 7.2 and 8.3 comes down to three steps:
- If you use a birth control pill, switch to a non-pill method, or add a barrier method.
- Do this for 4 weeks after you start.
- Do it again for 4 weeks after each dose increase.
The label also says that hormonal birth control that is not taken by mouth should not be affected. That covers methods like the patch, ring, shot, implant and hormonal IUD.
The Mounjaro label on DailyMed (revised August 2026) has the same contraception wording in section 8.3. Mounjaro is approved for type 2 diabetes and Zepbound for weight and sleep apnea, but they are the same drug, so the advice is the same.
The study behind the warning
Section 12.3 of the Zepbound label describes the study. People took a combined pill (0.035 mg ethinyl estradiol and 0.25 mg norgestimate) along with a single 5 mg dose of tirzepatide.
Peak blood levels of the pill's hormones dropped by 59%, 66% and 55% for ethinyl estradiol, norgestimate and norelgestromin. Total exposure over time dropped less, by 20%, 21% and 23%. The peak also came 2.5 to 4.5 hours later than usual.
Two things stand out. First, this was after a single dose, which is when the stomach effect is strongest. Second, the label does not say how much a drop like this changes the real chance of pregnancy. It simply treats it as enough to recommend backup protection.
How the 4-week windows add up on a normal schedule
The Zepbound label (section 2.1) starts everyone at 2.5 mg once a week for 4 weeks, then 5 mg. After that the dose can go up in 2.5 mg steps, each after at least 4 weeks on the current dose. The highest dose is 15 mg.
That means each new dose step opens a new 4-week backup window. Someone who steps up every 4 weeks from 2.5 mg to 15 mg would go through six of those windows (the start, then five increases), which works out to about the first 24 weeks of treatment. Someone who stays at 5 mg would only have the two windows: the start and the first increase.
A few practical points that follow from the label wording:
- The window is tied to dose changes, not to the calendar. If your prescriber holds you at one dose for months, no new window opens.
- Going back down to a lower dose is not a dose increase in the label's terms. But if you stop for a while and restart, ask your prescriber whether to treat it like a new start.
- Write down the date of every dose change. That is the only way to know when each 4-week window ends.
What the semaglutide labels say
Ozempic, Wegovy and Rybelsus contain semaglutide, a different GLP-1 drug. Their labels do not include the 4-week backup advice.
The Ozempic injection label on DailyMed says in section 7.2 that semaglutide did not affect the absorption of oral medicines to any clinically relevant degree in its studies. Section 12.3 lists an oral contraceptive (ethinylestradiol and levonorgestrel) among the drugs tested at steady state. The label still says to use caution with oral medicines in general.
The Wegovy label on DailyMed (revised 06/2026) says in section 7.2 that semaglutide 1 mg injection did not affect the absorption of oral medicines in its studies. It still advises monitoring oral medicines, especially ones that need close checks.
So the labels treat the two drug families differently on this point. If you switch from semaglutide to tirzepatide, the tirzepatide start counts as a new start, and the 4-week advice applies.
Planning a pregnancy
All of these labels address pregnancy, and the details differ.
- Ozempic and Wegovy: stop at least 2 months before a planned pregnancy, because semaglutide stays in the body a long time. This is in section 8.3 of the Ozempic and Wegovy labels.
- Rybelsus and Ozempic tablets: the same 2-month advice appears in section 8.3 of the oral semaglutide label on DailyMed.
- Zepbound: section 8.1 says weight loss offers no benefit during pregnancy and may cause fetal harm, and to stop Zepbound when a pregnancy is recognized. The label does not set a fixed number of weeks to stop before trying.
The Zepbound and Wegovy labels both list a pregnancy exposure registry in section 8.1, for anyone who becomes pregnant while taking the drug.
Stomach side effects and your pill
Nausea, diarrhea and vomiting top the list of common side effects in the Zepbound label, and its slow dose steps exist to reduce them (section 2.1). So the time you are most likely to feel sick is also the time the backup window applies.
The GLP-1 labels do not give rules for a pill you vomit up. Your birth control pill's own leaflet usually does, so keep it handy and check it if you get sick soon after taking a pill. When in doubt, ask your pharmacist.
A simple way to stay on top of it
- Tell your prescriber which birth control you use before your first dose.
- If it is a pill and you are starting tirzepatide, decide together: switch to a non-pill method, or add a barrier method for 4 weeks.
- Log the date of your first shot and every dose change.
- Count 4 weeks from each of those dates. That is your backup window.
- If you plan a pregnancy, talk to your prescriber early, since semaglutide needs 2 months off first.
Logging dose changes is the part most people forget. A GLP-1 tracker such as Dose Track keeps every shot and every dose step with its date, so you can look back and see exactly when each window started. If you are on tirzepatide, the Zepbound guide and Mounjaro guide lay out the dose steps in one place.
The bottom line
On Mounjaro or Zepbound, use backup or a non-pill method for 4 weeks after starting and after each dose increase. On Ozempic, Wegovy or Rybelsus there is no matching advice, but stop semaglutide 2 months before a planned pregnancy. Check your plan with your prescriber and keep a dated record of every dose change.

